Meet with ADVI Experts at Meeting on the Mesa

ADVI Health will be attending the Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa from October 10-12, 2023 in Carlsbad, California.

From our ADVI team, director of health policy and reimbursement, Alicia Silver, CEO and president, Marc Samuels, and head of marketing, Melyssa Nocar, will meet with clients throughout the event.

Want to meet with us at the event? Click Get in Touch to book a time that works for your schedule.

Join the Conversation
Marc Samuels, ADVI CEO and president, will be chairing two sessions on Thursday, October 12 at the event:

  • 9:15 – 10 am | Fireside Chat: Headwinds and Tailwinds Facing Patients, Providers, and Producers
    Chair: Marc Samuels, CEO, ADVI Health
    Speakers: Ellen Lukens, CEO, Deputy Director, Center for Medicare & Medicaid Innovation, CMS Innovation Center
  • 10 – 10:45 am | Medicare – A Look on the Cell Therapy Landscape
    Chair: Marc Samuels, CEO, ADVI Health
    Speakers: Stephanie Farnia, Principal, Nimitt Consulting
    Marianne Hamilton Lopez, Ph.D., Senior Research Director, Biomedical
    Innovation, Duke-Margolis Center for Health Policy
    Laura Okpala, Senior Director, Policy, Gilead Sciences
    Keren Shani, Executive Director, Cell & Gene Therapy, Trinity

Missed the event?  Hear ADVI Health’s Marc Samuels chat about some of the core themes discussed at the  Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa.

Speakers

Alicia Silver

Director

Marc Samuels

CEO and President

Melyssa Nocar

Head of Marketing

Further Resources:

ADVI insights

Insights,

| Allison Schneider - Senior Manager

ADVI Instant: Colorado PDAB Votes to Establish an Upper Payment Limit for Enbrel

Insights,

| Brenna Raines - Senior Director

ADVI Instant: CMS Releases Draft Part Two Guidance for the MPPP program
ADVI Angle Vertical

Insights,

| Marc Samuels - CEO and President

Top 5 Questions Clients Should be Asking in 2024

Insights,

| Brenna Raines - Senior Director

ADVI Instant: CMS Releases CY 2025 MA Changes and Part D Redesign Instructions